Vitruvia Medical AG
Vitruvia Medical AG, a technology company, operates in the healthcare sector. The company supplies circular systems for medical devices primarily in robot-assisted surgery. It also focusses on the repair, production, and trading of medical devices and surgical instruments. Vitruvia Medical AG was incorporated in 2017 and is based in Wohlen, Switzerland.
Vitruvia Medical AG (991) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, Vitruvia Medical AG (991) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Vitruvia Medical AG - Net Assets Trend (None–None)
This chart illustrates how Vitruvia Medical AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Vitruvia Medical AG (None–None)
The table below shows the annual net assets of Vitruvia Medical AG from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Vitruvia Medical AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Vitruvia Medical AG Competitors by Market Cap
The table below lists competitors of Vitruvia Medical AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kairous Acquisition Corp. Limited Warrants
NASDAQ:KACLW
|
$14.19K |
|
Agriculture Printing and Packaging JSC
VN:INN
|
$14.21K |
|
Colombo Investment Trust PLC
CM:CITN0000
|
$14.24K |
|
CAPITAL LTD. DL-0001
F:C8D
|
$14.24K |
|
Advanced Biomedical Technologies Inc
PINK:ABMT
|
$14.18K |
|
GreenBank Capital Inc
PINK:GRNBF
|
$14.18K |
|
OPCT3F
SA:OPCT3F
|
$14.15K |
|
BIOSTIME INTL
BE:8BI
|
$14.15K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Vitruvia Medical AG's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Vitruvia Medical AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Vitruvia Medical AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Vitruvia Medical AG's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Vitruvia Medical AG (991) | €- | N/A | N/A | $14.18K |
| Hanna Capital Corp (04U1) | $-79.29K | 0.00% | 0.00x | $116.52K |
| WESTMINSTER RES (08W) | $4.66 Million | -31.33% | 0.12x | $5.16 Million |
| Axonics Inc (0I3) | $570.14 Million | -10.47% | 0.16x | $3.29 Billion |
| Global Bioenergies SA (1DK) | $14.81 Million | -86.04% | 0.89x | $369.68K |
| GIEAG Immobilien AG (2GI) | $41.80 Million | 40.21% | 8.93x | $15.57K |
| 2invest AG (2INV) | $82.61 Million | -2.29% | 0.06x | $13.67 Million |
| PT Central Proteina Prima Tbk (4PT) | $3.42 Trillion | 11.74% | 1.00x | $6.90 Million |
| DGH Deutsche Grundwert Holding AG (5TR) | $0.00 | 0.00% | 0.00x | $18.45K |
| SOFTCHOICE CORP. (90Q) | $58.23 Million | -19.76% | 10.01x | $470.36 Million |
| ALBA SE (ABA) | $142.95 Million | 5.25% | 0.45x | $5.10 Million |